The effect of conventional and sustained delivery of levodopa on SH-SY5Y neuroblastoma cells

Biomedical Sciences Instrumentation

Volumn 41, Issue , 2005, Pages 382-387

  Martin, Tina Mitchell ^a   Benghuzzi, Hamed ^a   Tucci, Michelle ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Drug Delivery System; L dihydroxyphenylalanine (L dopa); Levodopa; Parkinson's Disease; SH SY5Y human neuroblastoma cells

Indexed keywords

CELLS; DISEASE CONTROL; ENZYMES; MORPHOLOGY; NEUROLOGY; OXIDATION; TOXIC MATERIALS; DISEASES; ENZYME KINETICS;

CELL NUMBER; DRUG DELIVERY; L-DIHYDROXYPHENYLALANINE (L-DOPA); QUINONES;

DRUG PRODUCTS; CONTROLLED DRUG DELIVERY;

ANTIPARKINSON AGENT; GLUTATHIONE; LEVODOPA;

APOPTOSIS; CELL LEVEL; CELL LOSS; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; HUMAN; HUMAN CELL; INCUBATION TIME; LOW DRUG DOSE; NERVE CELL LESION; NEUROBLASTOMA CELL; NEUROTOXICITY; SUSTAINED DRUG RELEASE;

ANTIPARKINSON AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEVODOPA; NEUROBLASTOMA;

DRUG DELIVERY SYSTEMS; L-DIHYDROXYPHENYLALANINE-(L-DOPA); LEVODOPA; PARKINSON'S DISEASES; SH-SY5Y HUMAN NEUROBLASTOMA CELLS;

EID: 17044402694     PISSN: 00678856     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. th ed). Philadelphia: WB Saunders Company.
2. rd ed.). pp. 1502-1503. Philadelphia: Lippincott-Raven.
3. Jenner, P. (1998). Oxidative mechanisms in nigral cell death in Parkinson's Disease. Movement Disorders. Supplement, 13, 24-34.
4. Olanow, C.W., Myllyla, V.V., Sotaniemi, K.A., et al (1998). Effects of selegeline on mortality in patients with Parkinson's disease. A meta-analysis. Neurology, 51, 825-830.
5. Kuhn, K., Wellen, J., Link, N., Maskri, L, Lubbert, H., & Stichel, C.C. (2003). The mouse MPTP model: gene expression changes in dopaminergic neurons. European Journal of Neuroscience, 17, 1-12.
6. Beal, M.F. (2003). Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Annals of the New York Academy of Sciences, 991, 120-131.
7. Kim, W.G., Mohney, R.P., Wilson, B., et al (2000). Regional difference in susceptibility to lipopolysacchardie-induced neurotoxicity in the rat brain: role of microglia. Journal of Neuroscience, 20, 6309-6316.
8. O'Neill, M.J., & Siemers, E. (2002). Pharmacological approaches to disease modifying therapies in Parkinson's disease. Expert Review Neurotherapeutics, 2, 89-104.
9. Silva, M.A., Mattern, C., Hacker, R., et al (1997). Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-dopa: on the role of benserazide pretreatment. Synapse, 27, 294-302.
10. Lang, A.E., & Lozano, A.M. (1998). Medical progress: Parkinson's disease. The New England Journal of Medicine, 339, 1130-1143.
11. Munchau, A., & Bhatia, K.P. (2000). Pharmacologic treatment in Parkinson's Disease. Postgraduate Medicine Journal, 76, 602-610.
12. Olanow, C.W., and Obeso, J.A. (2000). Pulsatile stimulation of dopamine receptors. Neurology, 55(Supplement 4) S72-S77.
13. Olanow, C.W., and Obeso, J.A. (2000). Preventing levodopa-induced dyskinesias. Annals of Neurology, 47, S167-178.
14. Obeso, J.A. (2000). Pathophysiology of levodopa dyskinesias. Annals of Neurology, 47, 22-34.
15. Simantov, R., Blinder, E., Ratovitski, T., Tauber, M., Gabbay, M., Porat, S. (1996). Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter. Neuroscience, 74, 39-50.
16. Junn, E., and Mouradian, M.M. (2001). Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. Journal of Neurochemistry, 78, 374-383.
17. Cheng, N.N., Maeda, T., Kume, T., et al (1996). Differential neurotoxicity induced by L-dopa and dopamine in culture striatal neurons. Brain Research, 743, 278-283.
18. Ziv, I., Zilkhafalb, R., Offen, D., Shirvan, A., et al (1997). Levodopa induces apoptosis in cultured neuronal cells: a possible accelerator of nigrostriatal degeneration in Parkinson's disease? Movement Disorders, 12, 17-23.
19. Alexander, T. Sortwell, C.E., Sladek, C.D., et al (1997). Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors. Cell Transplant, 6, 309-315.
20. Velez-Pardo, C., Del Rio, M.J., Verschueren, H., et al (1997). Dopamine and iron induce apoptosis in PC12 cells. Pharmacology and Toxicology, 80, 76-84.
21. Gomez-Santos, C., Ferrer, I., Santidrian, A.F., Barrachina, M., Gil, J., and Ambrisio, S. (2003). MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Research, 935, 32-39.
22. Lai, C.T., and Yu, P.H. (1997). Dopamine and L-B-3,4- dihydroxyphenylalanine hydrochloride (L-dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Biochemical Pharmacology, 53, 363-372.
23. Lai, C.T., and Yu, P.H. (1997). R(-)-deprenyl potentiates dopamine-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Toxicology and Applied Pharmacology, 142, 186-191.
24. Mytilineou, C., Walker, R.H., Jnobaptiste, R., & Olanow, C.W. (2003). Levodopa is toxic to dopamine neurons in an in vitro but not an in vivo model of oxidative stress. The Journal of Pharmacology and Experimental Therapeutics, 304, 792-800.
25. Simantov, R., Blinder, E., Ratovitski, T., Tauber, M., Gabbay, M., Porat, S. (1996). Dopamine-induced apoptosis in human neuronal cells: inhibition by nucleic acids antisense to the dopamine transporter. Neuroscience, 74, 39-50.
26. Emdadul, H. M., Asanuma, M., Higashi, Y., Miyazaki, I., et al (2003). Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochemica et Biophysica Acta, 1619, 39-52.
27. Gomez-Santos, C., Ferrer, I., Santidrian, A.F., Barrachina, M., et al (2003). Dopamine induces autophagic cell death and α-synuclein increase in human neuroblastoma SH-SY5Y cells. Journal of Neuroscience Research, 73, 341-350.
28. Malisza, K.L., McIntosh, A.R., Sveinson, S.E., and Hasinoff, B.B. (1996). Semiquinone free radical formation by daunorubicin aglycone incorporated into the cellular membranes of intact Chinese hamster ovary cells. Free Radical Research, 24, 9-18.
29. Han, S., Mytilineou, C., Cohen, G. (1996). L-DOPA up-regulates glutathione and protects mesencephalic cultures against oxidative stress. Journal of Neurochemistry, 66, 501-510.